source
- AstraZeneca opens 570,000-sq-ft Kendall Square R&D hub to boost cancer and biotech researchAstraZeneca inaugurated a 570,000-square-foot research and development facility in Kendall Square, Cambridge, Massachusetts. The 18-story building will host roughly 2,000 scientists working on chr…
- UK regulator adopts AI framework for medical devices and launches third AI Airlock phaseThe Medicines and Healthcare products Regulatory Agency (MHRA) announced that the UK government has adopted a set of recommendations on the use of artificial intelligence in medical devices. These…